A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The study will evaluate how well AZD6234 works and how safe it is in adults with excess weight or obesity. Efficacy of AZD6234 will be compared to placebo in percent body weight change from baseline at 68 weeks of treatment.
Epistemonikos ID: 1759b389ab0a5ee89bff70fefe598f1f17c36f0d
First added on: Aug 20, 2026